Product Code: GVR-2-68038-577-9
Intravascular Ultrasound Market Growth & Trends:
The global intravascular ultrasound market size is anticipated to reach USD 1.14 billion by 2030, according to a new report by Grand View Research, Inc., registering a CAGR of 5.1% from 2023 to 2030. The rising prevalence of cardiovascular disorders coupled with the increasing demand for effective diagnostic techniques is the key factor driving the market. Moreover, consistent technological advancements are further expected to boost market growth during the forecast period. Intravascular ultrasound (IVUS) is an effective intravascular imaging modality as this technology overcomes numerous disadvantages of angiography, which utilizes X-ray technology to create images.
Furthermore, the growing demand for advanced and accurate medical imaging is resulting in the rapid development of Artificial Intelligence (AI). For instance, in March 2021, GE Healthcare announced a portable Point-of-Care Ultrasound Device (POCUS) called Venue Fit, in addition to an industry-first AI tool for cardiac imaging. Favorable reimbursement policies for coronary intervention procedures in developed countries are further anticipated to boost industry growth over the forecast period. The Centers for Medicare & Medicaid Services (CMS) offers favorable healthcare insurance policies for various cardiovascular procedures.
This may increase the number of patients opting for such services. Some of the prominent companies in the industry are undertaking different initiatives, such as funding and acquisitions of medium- and small-sized businesses to expand their product portfolios and enhance their manufacturing capacities. For instance, in August 2020, Philips launched Affiniti CVx a cardiovascular ultrasound system. The solution is designed to help cardiology departments provide better care to more patients with enhanced efficiency and throughput.
Intravascular Ultrasound Market Report Highlights:
- Based on modality, the virtual histology IVUS segment accounted for the largest revenue share in 2022 owing to its wide range of applications and advantages in cardiology
- Based on products, the accessories segment held the largest revenue share in 2022. The segment is sub-categorized into catheters, guidewires, and others
- The diagnostic centers end-use segment is anticipated to register the fastest growth rate during the forecast period
- This growth can be attributed to the increasing number of establishments of standalone diagnostic centers
- Asia Pacific is expected to register the fastest growth rate from 2023 to 2030 on account of the presence of the target patient population, increasing healthcare awareness, and rising government funding for R&D & upcoming research projects
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.1.1. Modality
- 1.1.2. Product
- 1.1.3. End-use
- 1.1.4. Regional scope
- 1.1.5. Estimates and forecast timeline
- 1.2. Research Methodology
- 1.3. Information Procurement
- 1.3.1. Purchased database
- 1.3.2. GVR's internal database
- 1.3.3. Secondary sources
- 1.3.4. Primary research
- 1.3.5. Details of primary research
- 1.3.5.1. Data for primary interviews in North America
- 1.3.5.2. Data for primary interviews in Europe
- 1.3.5.3. Data for primary interviews in Asia Pacific
- 1.3.5.4. Data for primary interviews in Latin America
- 1.3.5.5. Data for Primary interviews in MEA
- 1.4. Information or Data Analysis
- 1.4.1. Data analysis models
- 1.5. Market Formulation & Validation
- 1.6. Model Details
- 1.6.1. Commodity flow analysis (Model 1)
- 1.6.1.1. Approach 1: Commodity flow approach
- 1.6.2. Volume price analysis (Model 2)
- 1.6.2.1. Approach 2: Volume price analysis
- 1.7. List of Secondary Sources
- 1.8. List of Primary Sources
- 1.9. Objectives
- 1.9.1. Objective 1
- 1.9.2. Objective 2
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Modality outlook
- 2.2.2. Product outlook
- 2.2.3. End-use outlook
- 2.2.4. Regional outlook
- 2.3. Competitive Insights
Chapter 3. Intravascular Ultrasound Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Penetration & Growth Prospect Mapping
- 3.3. Industry Value Chain Analysis
- 3.3.1. Reimbursement framework
- 3.4. Market Dynamics
- 3.4.1. Market driver analysis
- 3.4.1.1. Rising prevalence of cardiovascular diseases
- 3.4.1.2. Rising incidence of diabetes across the globe
- 3.4.1.3. Favorable reimbursement policies for coronary intervention procedures
- 3.4.1.4. Lack of substitutes in the market
- 3.4.1.5. Launch of new product lines in the market
- 3.4.2. Market restraint analysis
- 3.4.2.1. Minimal use of IVUS catheters in developing countries
- 3.4.2.2. Lack of skilled professionals in low and middle-income countries
- 3.4.2.3. Stringent regulatory policies related to product approval
- 3.5. Intravascular Ultrasound Market Analysis Tools
- 3.5.1. Industry Analysis - Porter's Five Forces
- 3.5.1.1. Supplier power
- 3.5.1.2. Buyer power
- 3.5.1.3. Substitution threat
- 3.5.1.4. Threat of new entrant
- 3.5.1.5. Competitive rivalry
- 3.5.2. PESTEL Analysis
- 3.5.2.1. Political landscape
- 3.5.2.2. Technological landscape
- 3.5.2.3. Economic landscape
- 3.5.3. Major Deals & Strategic Alliances Analysis
- 3.5.4. Market Entry Strategies
Chapter 4. Intravascular Ultrasound Market: Modality Estimates & Trend Analysis
- 4.1. Definitions and Scope
- 4.1.1. Virtual Histology IVUS
- 4.1.2. iMap IVUS
- 4.1.3. Integrated Backscatter IVUS
- 4.2. Modality Market Share, 2022 & 2030
- 4.3. Segment Dashboard
- 4.4. Global Intravascular Ultrasound Market by Modality Outlook
- 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 4.5.1. Virtual Histology IVUS
- 4.5.1.1. Virtual histology IVUS market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.2. Imap IVUS
- 4.5.2.1. Imap IVUS market estimates and forecast 2018 to 2030 (USD Million)
- 4.5.3. Integrated backscatter IVUS
- 4.5.3.1. Integrated backscatter IVUS market estimates and forecast 2018 to 2030 (USD Million)
Chapter 5. Intravascular Ultrasound Market: Product Estimates & Trend Analysis
- 5.1. Definitions and Scope
- 5.1.1. Consoles
- 5.1.2. Accessories
- 5.2. Product Market Share, 2022 & 2030
- 5.3. Segment Dashboard
- 5.4. Global Intravascular Ultrasound Market by Product Outlook
- 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 5.5.1. Consoles
- 5.5.1.1. Consoles market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.2. Accessories
- 5.5.2.1. Accessories market estimates and forecast 2018 to 2030 (USD Million)
- 5.5.2.1.1. Catheters
- 5.5.2.1.1.1. Catheters market estimates and forecast 2018 to 2030 (USD
- 5.5.2.1.2. Guide wires
- 5.5.2.1.2.1. Guide wires market estimates and forecast 2018 to 2030 (USD
- 5.5.2.1.3. Others
- 5.5.2.1.3.1. Others market estimates and forecast 2018 to 2030 (USD
Chapter 6. Intravascular Ultrasound Market: End-use Estimates & Trend Analysis
- 6.1. Definitions and Scope
- 6.1.1. Hospitals
- 6.1.2. Diagnostic imaging centers
- 6.1.3. Academic and research institutes
- 6.2. End-use Market Share, 2022& 2030
- 6.3. Segment Dashboard
- 6.4. Global Colposcopy Market by End-use Outlook
- 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
- 6.5.1. Hospitals
- 6.5.1.1. Hospitals estimates and forecast 2018 to 2030 (USD Million)
- 6.5.2. Diagnostic Imaging Centers
- 6.5.2.1. Diagnostic centers market estimates and forecast 2018 to 2030 (USD Million)
- 6.5.3. Academic & Research Institutes
- 6.5.3.1. Academic and research institutes market estimates and forecast 2018 to 2030 (USD Million)
Chapter 7. Intravascular Ultrasound Market: Regional Estimates & Trend Analysis
- 7.1. Regional market share analysis, 2018 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Global Regional Market Snapshot
- 7.4. Regional Market Share and Leading Players, 2022
- 7.4.1. North America
- 7.4.2. Europe
- 7.4.3. Asia Pacific
- 7.4.4. Latin America
- 7.4.5. Middle East and Africa
- 7.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
- 7.5.1. North America
- 7.5.2. Europe
- 7.5.3. Asia Pacific
- 7.5.4. Latin America
- 7.5.5. Middle East and Africa
- 7.6. Market Size, & Forecasts, Volume and Trend Analysis, 2018 to 2030:
- 7.7. North America
- 7.7.1. Market estimates and forecast, 2018 - 2030
- 7.7.2. U.S.
- 7.7.2.1. Market estimates and forecast, 2018 - 2030
- 7.7.3. Canada
- 7.7.3.1. Market estimates and forecast, 2018 - 2030
- 7.8. Europe
- 7.8.1. U.K.
- 7.8.1.1. Market estimates and forecast, 2018 - 2030
- 7.8.2. Germany
- 7.8.2.1. Market estimates and forecast, 2018 - 2030
- 7.8.3. France
- 7.8.3.1. Market estimates and forecast, 2018 - 2030
- 7.8.4. Italy
- 7.8.4.1. Market estimates and forecast, 2018 - 2030
- 7.8.5. Spain
- 7.8.5.1. Market estimates and forecast, 2018 - 2030
- 7.9. Asia Pacific
- 7.9.1. Japan
- 7.9.1.1. Market estimates and forecast, 2018 - 2030
- 7.9.2. China
- 7.9.2.1. Market estimates and forecast, 2018 - 2030
- 7.9.3. India
- 7.9.3.1. Market estimates and forecast, 2018 - 2030
- 7.9.4. South Korea
- 7.9.4.1. Market estimates and forecast, 2018 - 2030
- 7.9.5. Australia
- 7.9.5.1. Market estimates and forecast, 2018 - 2030
- 7.10. Latin America
- 7.10.1. Brazil
- 7.10.1.1. Market estimates and forecast, 2018 - 2030
- 7.10.2. Mexico
- 7.10.2.1. Market estimates and forecast, 2018 - 2030
- 7.10.3. Argentina
- 7.10.3.1. Market estimates and forecast, 2018 - 2030
- 7.10.4. Colombia
- 7.10.4.1. Market estimates and forecast, 2018 - 2030
- 7.11. MEA
- 7.11.1. Saudi Arabia
- 7.11.1.1. Market estimates and forecast, 2018 - 2030
- 7.11.2. South Africa
- 7.11.2.1. Market estimates and forecast, 2018 - 2030
- 7.11.3. UAE
- 7.11.3.1. Market estimates and forecast, 2018 - 2030
Chapter 8. Competitive Landscape
- 8.1. Recent Developments & Impact Analysis, By Key Market Participants
- 8.2. Company/Competition Categorization
- 8.3. Vendor Landscape
- 8.3.1. List of key distributors and channel partners
- 8.3.2. Key customers
- 8.3.3. Key company market share analysis, 2022
- 8.3.4. Canon Medical Systems Corporation
- 8.3.4.1. Company overview
- 8.3.4.2. Financial performance
- 8.3.4.3. Modality benchmarking
- 8.3.4.4. Strategic initiatives
- 8.3.5. Boston Scientific Corporation
- 8.3.5.1. Company overview
- 8.3.5.2. Financial performance
- 8.3.5.3. Modality benchmarking
- 8.3.5.4. Strategic initiatives
- 8.3.6. GE Healthcare
- 8.3.6.1. Company overview
- 8.3.6.2. Financial performance
- 8.3.6.3. Modality benchmarking
- 8.3.6.4. Strategic initiatives
- 8.3.7. Koninklijke Philips N.V.
- 8.3.7.1. Company overview
- 8.3.7.2. Financial performance
- 8.3.7.3. Modality benchmarking
- 8.3.7.4. Strategic initiatives
- 8.3.8. Siemens Healthcare Gmbh
- 8.3.8.1. Company overview
- 8.3.8.2. Financial performance
- 8.3.8.3. Modality benchmarking
- 8.3.8.4. Strategic initiatives
- 8.3.9. Hitachi Ltd
- 8.3.9.1. Company overview
- 8.3.9.2. Financial performance
- 8.3.9.3. Modality benchmarking
- 8.3.9.4. Strategic initiatives
- 8.3.10. Mindray Medical International Limited
- 8.3.10.1. Company overview
- 8.3.10.2. Financial performance
- 8.3.10.3. Modality benchmarking
- 8.3.10.4. Strategic initiatives
- 8.3.11. Fujifilm Corporation, Inc
- 8.3.11.1. Company overview
- 8.3.11.2. Financial performance
- 8.3.11.3. Modality benchmarking
- 8.3.11.4. Strategic initiatives
- 8.3.12. Samsung Medison Co. Ltd
- 8.3.12.1. Company overview
- 8.3.12.2. Financial performance
- 8.3.12.3. Modality benchmarking
- 8.3.12.4. Strategic initiatives
- 8.3.13. Chison Medical Technologies Co. Ltd
- 8.3.13.1. Company overview
- 8.3.13.2. Financial performance
- 8.3.13.3. Modality benchmarking
- 8.3.13.4. Strategic initiatives